( GlaxoSmithKline is in a spree of produc...)GlaxoSmithKline launches diabetes and cancer drugs,Health

GlaxoSmithKline is in a spree of producing new diabetes and cancer drugs which it hopes will increase its sales this year. After the recent U.S. drug approvals it is starting // to market two of its new diabetes drug Avandaryl and Avandamet which is found to be effective in treating type 2 diabetes.

The drug Avandaryl is manufactured by combining the two drugs Avandina and Sulphonylureas and the drug Avandamet is produced by the combination of Avandina and Metformin. Glaxo drug Hycamtin is found to be effective in improving the quality of life in patients with cancer and is also found to increase the survival rate. Hycamtin is used in treating ovarian cancers is also found to be effective in treating Lung cancer and is also prescribed for treating relapsed small cell lung cancer, The feasibility of using oral hycamtin is being tried by Glaxo as hycamtin is now administered as an infusion.

GlaxoSmithKline is developing new drugs for cancer and diabetes and the company feels that its drug in the pipeline would be soon getting its FDA approval and would surely help in the treatment of patients and will have important health advances in treating patients.


'"/>




Page: 1
Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
4. FDA Mislead On Asthma Drug By GlaxoSmithKline
5. GlaxoSmithKline Defends Its Products
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS